Clinical Trial Announcement

UCLA Now Testing New Treatment For AIDS and Lymphoma

Published in AIDS Weekly, September 21st, 1998

The University of California Los Angeles (UCLA) Jonsson Cancer Center has begun an experimental treatment for patients with HIV related non-Hodgkin's lymphoma. The high-dose chemotherapy treatment could prolong survival and help strengthen the immune system.

Dr. Rafael Amado, who heads the Cancer Center team administering the treatment, said eligible patients must be infected with the AIDS virus and have HIV related lymphoma that is responsive to chemotherapy.

Before they receive the high-dose chemotherapy, patients are treated with a standard dose of chemotherapy. They then are given a hormone to stimulate growth of their stem cells, primitive...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1998-09-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry